Eli Lilly and Company, D-Wave Quantum, and Thermo Fisher Scientific are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in the research, development, manufacture, and sale of medications and medical treatments. Investors buy and sell these stocks to gain exposure to the pharmaceutical sector’s potential for growth, driven by factors like drug approvals, patent lifecycles, and healthcare demand. Performance in this sector can be influenced by regulatory decisions, clinical trial results, and industry partnerships. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Eli Lilly and Company stock traded up $4.32 during trading hours on Friday, hitting $770.00. 2,068,266 shares of the stock traded hands, compared to its average volume of 3,650,297. The firm's 50-day moving average price is $770.87 and its two-hundred day moving average price is $799.95. The company has a current ratio of 1.15, a quick ratio of 0.97 and a debt-to-equity ratio of 2.00. The company has a market cap of $729.76 billion, a PE ratio of 65.76, a PEG ratio of 1.40 and a beta of 0.40. Eli Lilly and Company has a one year low of $677.09 and a one year high of $972.53.
Read Our Latest Research Report on LLY
D-Wave Quantum (QBTS)
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.
D-Wave Quantum stock traded up $2.20 during trading hours on Friday, hitting $18.67. 82,418,579 shares of the stock traded hands, compared to its average volume of 44,709,735. The firm's 50-day moving average price is $10.56 and its two-hundred day moving average price is $7.75. The company has a market cap of $5.46 billion, a PE ratio of -44.45 and a beta of 1.49. D-Wave Quantum has a one year low of $0.75 and a one year high of $19.77.
Read Our Latest Research Report on QBTS
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Thermo Fisher Scientific stock traded up $3.63 during trading hours on Friday, hitting $401.99. 2,629,538 shares of the stock traded hands, compared to its average volume of 1,908,231. The firm's 50-day moving average price is $420.74 and its two-hundred day moving average price is $495.93. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. The company has a market cap of $151.75 billion, a PE ratio of 24.32, a PEG ratio of 2.99 and a beta of 0.78. Thermo Fisher Scientific has a one year low of $390.50 and a one year high of $627.88.
Read Our Latest Research Report on TMO
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
